论文部分内容阅读
为了探索流行性出血热(EHF)的有效病因治疗,近4～5年来我院应用三氮唑核苷对110例EHF 患者进行治疗并作对比观察,现报道如下。材料与方法病例选择110例为1987年10月至1992年4月所收治的病程在5天以内的 EHF 患者,全部病例均符合1986年全国 EHF 会议的诊断及分期标准并经 EHF～IgM 证实,入院后随机分组。治疗组:男43例,女21例,年龄15～65岁,(平均33.8±11.05岁),病程平均3.98±1.15日,体温38.5～41℃(平均39.04±1.48℃)。12例伴低血压(平均血压10.8±2.4/8.2±1.2kpa),对照组:男32例,女14例,年龄18～60岁平均36.21±12.38岁,病程平均4.06±0.96日,体温38.4～
In order to explore the effective cause of hemorrhagic fever (EHF) treatment, nearly 4 to 5 years in our hospital ribavirin 110 cases of EHF patients were treated and compared observations are reported below. MATERIALS AND METHODS Selection of 110 cases of EHF patients whose duration of disease was within 5 days from October 1987 to April 1992 were all confirmed by the diagnostic and staging criteria of the EHF meeting in 1986 and confirmed by EHF IgM. Randomly grouped after admission. Treatment group: 43 males and 21 females, aged 15-65 years (mean, 33.8 ± 11.05 years) with an average duration of 3.898 ± 1.15 days and body temperature of 38.5-41 ° C (mean, 39.04 ± 1.48 ° C). 12 cases with hypotension (average blood pressure 10.8 ± 2.4 / 8.2 ± 1.2kpa), control group: 32 males and 14 females, aged 18 to 60 years old average 36.21 ± 12.38 years, duration of an average of 4.06 ± 0.96 days, body temperature 38.4 ~